ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $519,000 | -7.2% | 396,362 | +24.7% | 0.01% | +16.7% |
| Q4 2021 | $559,000 | -46.6% | 317,800 | -34.2% | 0.01% | -57.1% |
| Q3 2021 | $1,047,000 | +705.4% | 482,663 | +1202.2% | 0.01% | +1300.0% |
| Q2 2021 | $130,000 | -0.8% | 37,064 | +206.0% | 0.00% | 0.0% |
| Q4 2020 | $131,000 | -39.6% | 12,112 | +16.6% | 0.00% | -83.3% |
| Q2 2020 | $217,000 | – | 10,384 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |